Motoo Nomura

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer

Tomoya Yokota, Takashi Ura, Norio Shibata et al. · British Journal of Cancer · 2011 · 413 citations · Full text

Medicine, Oncology, Pathology +17

Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors

Motoo Nomura, Ryosuke Nagatomo, Keitaro Doi et al. · JAMA Network Open · 2020 · 378 citations · Full text

Life Sciences, Immunology, Oncology +17

Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab

Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto et al. · PLoS ONE · 2019 · 135 citations · Full text

Medicine, Endocrinology, Nuclear Medicine +16

Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System

Chigusa Morizane, Nozomu Machida, Yoshitaka Honma et al. · JAMA Oncology · 2022 · 93 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study

Chihiro Kondoh, Kohei Shitara, Motoo Nomura et al. · BMC Palliative Care · 2015 · 85 citations · Full text

Medicine, Oncology, Surgery +16